-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
Five Tips for Negotiating Clinical Trial Budgets in Inflationary Times
May 25, 2023
Rapid inflation and staffing shortages make it more difficult for research sites and pharmaceutical sponsors to agree to a clinical trial budget. According to Jenn Hill, Director of Clinical Site Contracting and Payments for Vertex Pharmaceuticals, inflation and high attrition rates have complicated the relationship between sites and sponsors. Sites respond to inflation with expanded budgets, extra reimbursements, and, in some cases, annual price sheets with increased rates.
Negotiating budgets takes longer as sponsors research requests to justify new budget items, and staffing shortages affect site response times. Supply chain and vendor lags are also taking their toll on sites. Here are five ways sponsors should respond in these inflationary times.
-
Be mindful and communicate frequently with sites
Hill advises sponsors to empathize and consider how frustrated sites are with inflation, staffing issues, and vendor delays. “Business as usual” isn’t working in today’s market, so it’s essential to have live conversations early in the negotiation process. She also recommends continuing to meet and engage with sites after distributing the award so that sponsors stay aware of any site delays or problems. Be willing to account for additional site effort and personnel time in this environment, such as for supply chain issues and sponsor/vendor turnover. Remember that fair market value (FMV) does not mean one-size-fits-all.
-
Back your decisions with industry data.
Access to detailed data is invaluable in budget negotiations and in demonstrating FMV. Sponsors should review fee requests in detail, and sites should provide documentation to justify price hikes. Reviewing individual codes and fees takes time, but tools like IQVIA GrantPlan help sponsors assess whether sites’ requests are reasonable. Vertex relies on GrantPlan’s benchmark data to lay the groundwork for their negotiations.
-
Take advantage of multiple tools and benchmarks.
IQVIA GrantPlan users can take steps to make sure they use the most relevant benchmarks and take advantage of all the tools available to build their budgets.
- Leverage the Pricelist benchmarks. These are costs populated from IQVIA’s internal data sources plus publicly available data sources, including country-level economic indicators, country-level source data, actual data, and others.
- Use the Upper Limit tool, which calculates a defined percentage above a chosen benchmark level.
- Use the Cost Per Patient tool. View global industry data at a cost-per-patient level alongside your own historical data. It serves as an additional comparison against your Cost Per Patient amounts before or after building your detailed line-item budgets.
While the majority of GrantPlan users build their studies on the Median benchmark, it may be appropriate to consider using the High benchmark or the Upper Limit during current inflationary times.
-
Keep your data updated.
Many budget planners begin a new study in GrantPlan by copying a previous one. While this is a time-saving feature, it’s important to remember to update your benchmark version and exchange rates after copying a previous study.
GrantPlan refreshes its budget and exchange rate data quarterly. However, metrics pulled in November 2022 showed that only 14% of the studies created or modified in 2022 by sponsors were built on the most current benchmarks available that year in August and October. Essentially, 86% of those studies may have used benchmark versions that didn’t incorporate the newest methodology or the most recent inflation rates, making them less relevant in today’s volatile market.
Benchmarks should also be updated at pivotal moments in a study’s life cycle, such as when starting a new cohort.
-
Adopt the Site Budget Capture tool.
GrantPlan represents a strategic partnership between IQVIA Technologies, pharmaceutical sponsors, and contract research organizations (CROs), whereby companies that license the product agree to provide final site budget data back into the tool. Site Budget Capture (SBC) is an IQVIA GrantPlan feature that provides a direct link for users to input final budgets. It can be utilized internally as part of an approval or escalation process and/or externally with sites to negotiate directly.
SBC also ensures site-level data are available to further enable additional GrantPlan functionality, such as visibility into previously negotiated costs. Adoption of SBC by sponsors and CROs will make it faster and easier to report data back into GrantPlan, which will ultimately elevate the industry’s confidence in the timeliness and relevance of the benchmarks and speed up budget negotiations.
GrantPlan’s benchmark tools are a vital resource when negotiating site budgets. You can hear more on this topic in a lively and informative webinar recorded several months back by my IQVIA Technologies colleagues and me, along with Jenn Hill. Watch the replay of Sky-High Inflation And The Great Resignation: The Impact On Clinical Site Budgeting, hosted by Clinical Leader, or download the whitepaper on this topic.